News for Jaguar Health, Inc. (JAGX)

Click here to registerDiscussion will focus on company's May 2025 meeting with the FDA to review the statistically significant responder analysis results for th

Jaguar Health (JAGX) recently summarized outcomes from its Type C Meeting with the U.S. Food and Drug Administration's Division of Gastroenterology on May 28, 2

Significant milestone for Jaguar Health (JAGX) as FDA discusses potential approval pathways for crofelemer. Breast cancer patient subgroup in Phase 3 tr

Click here to register SAN FRANCISCO, CA / ACCESS Newswire / June 6, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's fou

Key Highlights: Jaguar Health's (JAGX) upcoming virtual fireside chat is part of Lytham Partners' Spring 2025 Spotlight Series.

SAN FRANCISCO, CA / ACCESS Newswire / May 21, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company"), today announced that it has entered into def

SAN FRANCISCO, CA / ACCESS Newswire / May 21, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company"), today announced that it has entered into def

Jaguar Health (JAGX) has finalized agreements for a registered direct offering involving the sale of 246,306 shares of its common stock, priced at $6.09 per sha

MIAMI, May 21, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 82nd Emerging Growth Con

**media[632753]**

**media[631374]**

Jaguar Health (JAGX) is making headlines as First Berlin has initiated coverage on the stock with a "Buy" rating. This announcement was made by analyst Christia

Release Date: May 15, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Increased demand

May 15, 2025 / 08:15PM GMTOperator Greetings, and welcome to Jaguar Health's May 15, 2025, investor webcast. Before I turn the call over to management, I'd like

The combined net Q1 2025 revenue of approximately $2.2 million for prescription and non-prescription products, including license revenue, decreased approximatel

Crofelemer, a novel plant-based anti-secretory prescription drug, has been granted Orphan Drug Designation by the FDA and the European Medicines Agency (EMA) fo

SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / April 4, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that, effective Apri

MIAMI, March 25, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com, a leading independent small cap media portal, announces the schedule of the 80th Emerging Growth

Reverse split approved at March 2025 Special Meeting of StockholdersShares of Jaguar Health common stock to begin trading on split-adjusted basis on March 24, 2